bf/NASDAQ:RNA_icon.jpeg

NASDAQ:RNA

Avidity Biosciences

  • Stock

USD

Last Close

69.78

06/11 21:01

Market Cap

4.07B

Beta: −0.10

Volume Today

1.06M

Avg: 1.32M

PE Ratio

−4.46

PFCF: −4.85

OverviewFinancialsAPI

    Description

    Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease; AOC 1044 for the...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -1.2-1-0.8-0.6-0.4-0.22019-03-302020-03-312021-08-092023-05-092024-08-132025-06-13

    Revenue (Estimate*)

    2M4M6M8M10M12M2019-03-302020-03-312021-08-092023-05-092024-08-132025-06-13

    *Estimate based on analyst consensus